Selected Publications
View all on PubMed
Kim YC, Shin M, Hackett S, Hsueh TH, Lima e Silva R, Date A, Han H, Kim BJ, Xiao A, Kim Y, Ogunnaike L, Anders NA, Hemingway A, He P, Jun AS, McDonnell PJ, Eberhart C, Pitha I, Zack DJ, Campochiaro PA, Hanes J, Ensign LM. Gelling hypotonic polymer solution for extended topical drug delivery to the eye, Nature Biomedical Engineering, 2020; 4(11):1053-1062
Josyula A, Omiadze R, Parikh KS, Kanvinde P, Appel MB, Patel P, Saeed H, Sutar Y, Anders NA, He P, Rudek M, McDonnell PJ, Hanes J, Date A, Ensign LM. An ion-paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection, BioTM, 2021; 6(3):e10238
Hsueh TH, Kim YC, Pitha I, Shin MD, Berlinicke CA, Chou RT, Kimball E, Schaub J, Quillen S, Leo KT, Han H, Xiao A, Kim Y, Appell MB, Rai U, Kwon H, Kolodziejski P, Ogunnaike L, Anders NA, Hemingway A, Jefferys J, Date AA, Eberhart C, Johnson TV, Quigley HA, Zack DJ, Hanes J, Ensign LM. Ion-complex microcrystal formulation provides sustained delivery of a multimodal kinase inhibitor from the subconjunctival space for protection of retinal ganglion cells, Pharmaceutics, 2021; 13(5):647
Hsueh TH, Chou RT, Rai U, Liyanage WS, Appell MB, Davison C, Kolodziejski P, Mozzer A, Leo KT, Kwon HY, Kim YC, Pitha I, Hanes J, Cummings MP, Ensign LM. Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery, Nat Comm, 2023;14:2509
Patents
Patent # US Patents 9,056,057; 9,393,212; 9.393,213; 9,415,020; 9,532,955; 9,737,491; 10,092,509; 10,058,511; 10,485,757; 10,646,434B2; 10,668,025; 10,736,854B2 |
Patent # AU2011323250B2; CN104936620A; AU2013209452B2; RU2598627C2; K101811918B1; AU2016200707B2; CA2863632C; AU2016211696; AU2013256130B2; JP6360039B2; EP2635254B1; EP2804632B1; CA2816997C; CA2974715A1; AU2018201772B2; JP6816065B2 |
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.